ENDOMETRIAL HYPERPLASIA

Clinical trials for ENDOMETRIAL HYPERPLASIA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL HYPERPLASIA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 1

Weight-loss drug plus IUD aims to save uterus in women at cancer risk

Disease control Terminated

This study was designed to see if combining a weight-loss drug (semaglutide) with a hormone-releasing IUD could help premenopausal women with obesity and a precancerous uterine condition keep their uterus and avoid cancer. It planned to enroll women who wanted to preserve their f…

Matched conditions: ENDOMETRIAL HYPERPLASIA

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated May 11, 2026 20:52 UTC

ENDOMETRIAL HYPERPLASIA

Get alerted when new ENDOMETRIAL HYPERPLASIA trials appear

Weight-loss drug plus IUD aims to save uterus in women at cancer risk